Newsfeeds - Spark Newswire

7 minute read

Transcript: Jason Raznick’s Conversation with Mr. Wonderful Kevin O’Leary At The Benzinga Psychedelics Conference

Today, 2:54 PM

On this special edition of the RazReport, Benzinga Founder & CEO Jason Raznick sits down with Kevin O'Leary AKA Mr. Wonderful at the Benzinga Psychedelics Capital Conference to discuss why he's investing in psychedelics.

CMPS

2 minute read

Landmark Gathering Of Psychedelics Executives And Scientists To Take Place In London May 11

By Natan Ponieman

Today, 2:54 PM

As the field of psychedelic medicine moves forward and international borders begin to open up, an expanding offering of conferences and live events are becoming available for investors, industry people and the general public.

CMPS

9 minute read

Pro-Patient Psychedelic Treatments Are Finally Moving Forward In A ‘New Paradigm Shift’

By Andrew Rossow

Today, 2:54 PM

Last week, Benzinga’s Psychedelics Capital Conference brought a premier gathering of the biggest publicly traded psychedelics companies in North America with forward-thinking investors to Miami, where the hottest topic seemed to revolve around LSD and derivative molecules.

MNMD

1 minute read

ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today

By Benzinga Insights

Today, 2:54 PM

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.97% at $4.97

ALID

1 minute read

Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today

By Benzinga Insights

Today, 2:54 PM

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 3.49% at $0.87

ALID

1 minute read

Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today

By Benzinga Insights

Today, 2:54 PM

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.57% at $0.33

ALID

2 minute read

EXCLUSIVE: Breaking Down Public Vs. Private Psychedelic Investments

By Aaron Bry

Today, 2:54 PM

For many private companies, the goal is clear: to go public. For others, the goal is an acquisition. Either way, private companies offer attractive potential for investors, especially in emerging markets. And the psychedelic space is just that.

ATAI

2 minute read

EXCLUSIVE: Why Kevin O’Leary Of ‘Shark Tank’ Says Public Psychedelics Companies Will Need To Merge

By Dustin Blitchok

Today, 2:54 PM

The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday. Investors never get the opportunity to position themselves in a brand new sector, “Mr.

ATAI